Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how the National Institute for Health and Care Research's Dementia Translational Research Collaborative plans to work with a Clinical Trial Acceleration Network for dementia to increase the UK’s share of clinical trials.
The Dementia Translational Research Collaboration (D-TRC) is funded by the Department via the National Institute for Health & Care Research. The D-TRC plays a critical role in coordinating dementia research in early phase clinical trials in the United Kingdom and seeks to offer a wider, more collaborative and cohesive network. The D-TRC's over-arching goal is the elevation of the UK as the world-leading place to conduct early phase clinical trials in dementia.
The Government will publish a full response to the Lord O’Shaughnessy independent review into commercial clinical trials in autumn 2023. The response will include an update on progress and implementation of the initial five headline commitments and foundational actions that the government made in May 2023 as well as all other recommendations in the review.